EUVIMEDEUVIMED entdecken
Crossref

Activation of IL-17/CEBPB/PFKFB3 triggers energy metabolic switching and goblet cell differentiation in ulcerative colitis

Hui Zhao, Zhiliang Hu

Biochemical Pharmacology · 2026-03 · 245 · 117654

DOI: 10.1016/j.bcp.2025.117654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-03. Verfasst von Hui Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anorectal Surgery, Affiliated Hospital of Jiangnan University, Wuxi 214122 Jiangsu, PR China. Hauptthemen laut MEDLINE: Goblet Cells, Colitis, Ulcerative, Phosphofructokinase-2, Cell Differentiation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Goblet cell depletion, frequently reported as a symptom of ulcerative colitis (UC), may reflect a combination of increased mucus release, decreased mucus storage, and altered goblet cell differentiation. Here, we studied the underlying mechanisms of CCAAT/enhancer-binding protein beta (CEBPB), which is enriched in interleukin (IL)-17 signaling, in goblet cell differentiation during UC. The IL-17/CEBPB/6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) signaling axis in vivo was elicited through an IL-17A-neutralizing antibody and adeno-associated viruses targeting goblet cells. Goblet cells were used to assess the effects of IL-17/CEBPB/PFKFB3 signaling on goblet cell differentiation. IL-17 signaling activated CEBPB-mediated PFKFB3 transcription in goblet cells of dextran sodium sulfate-induced mice and drove a switch in the mode of energy metabolism from oxidative phosphorylation to aerobic glycolysis in goblet cells. The abnormal glycolytic activity of goblet cells was detrimental to cell differentiation and maturation, leading to decreased mucin secretion and weakened intestinal barrier capacity of the goblet cells, which led to the progression of UC. Overall, these results indicate that IL-17 pro-inflammatory signaling activates CEBPB/PFKFB3 expression to drive aerobic glycolysis in goblet cells, leading to goblet cell dysfunction and UC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Goblet CellsColitis, UlcerativePhosphofructokinase-2Cell DifferentiationCCAAT-Enhancer-Binding Protein-betaInterleukin-17Energy MetabolismAnimalsMiceMice, Inbred C57BLHumansMaleDextran Sulfate

Stichwörter der Autor:innen

CEBPBGlycolysisGoblet cell differentiationPFKFB3Ulcerative colitis

Substanzen

Phosphofructokinase-2CCAAT-Enhancer-Binding Protein-betaInterleukin-17PFKFB3 protein, mouseCebpb protein, mouseDextran SulfateCEBPB protein, humanPFKFB3 protein, human

Autor:innen und Institutionen

  • Department of Anorectal Surgery, Affiliated Hospital of Jiangnan University, Wuxi 214122 Jiangsu, PR China.
  • Department of Anorectal Surgery, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi 214071 Jiangsu, PR China. Electronic address: wxzy038@njucm.edu.cn.

Zitieren

APA

Zhao, H., & Hu, Z. (2026). Activation of IL-17/CEBPB/PFKFB3 triggers energy metabolic switching and goblet cell differentiation in ulcerative colitis. Biochemical Pharmacology, 245, 117654. https://doi.org/10.1016/j.bcp.2025.117654

Vancouver

Zhao H, Hu Z. Activation of IL-17/CEBPB/PFKFB3 triggers energy metabolic switching and goblet cell differentiation in ulcerative colitis. Biochemical Pharmacology. 2026;245:117654. doi:10.1016/j.bcp.2025.117654

BibTeX
@article{Zhao2026,
  author = {Zhao, Hui and Hu, Zhiliang},
  title = {Activation of IL-17/CEBPB/PFKFB3 triggers energy metabolic switching and goblet cell differentiation in ulcerative colitis},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {245},
  pages = {117654},
  doi = {10.1016/j.bcp.2025.117654}
}
Kostenlos starten →